Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 15Breast Neoplasms 10Neoplasms 2Advanced Breast Cancer 2Recurrence 1Prostate Adenocarcinoma 1Primary Ovarian Insufficiency 1Myofibroma 1Hormone-sensitive Metastatic Breast Cancer 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1

Interventions

Letrozole 2Goserelin 2Fulvestrant 2olaparib 1abemaciclib 1Trastuzumab 1Lead 1Aromatase Inhibitors 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Advanced Breast Cancer × Goserelin × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated
2 enrolled 10 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡